Stereotaxis, Inc.
For the period ended Mar 31, 2026. Filed May 13, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 13, 2026
STXS$1.03-9.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Convertible Preferred Stock and Stockholders’ Equity
Three Months Ended March 31, 2025
| (in thousands, except share amounts) · Convertible Preferred Stock Series A (Mezzanine) · Common Stock · Additional Paid-In Capital · Treasury Stock · Accumulated Deficit · Total Stockholders’ Equity (Deficit) | ||||||||
|---|---|---|---|---|---|---|---|---|
| Shares | Amount | Shares | Amount | Amount | Amount | Amount | Amount | |
| Balance at December 31, 2024 | 21,458 | $5,352 | 85,326,557 | $85 | $567,926 | $(206) | $(561,725) | $6,080 |
| Stock issued for the exercise of stock options | - | - | 4,103 | - | 1 | - | - | 1 |
| Stock-based compensation | - | - | 120,908 | - | 2,535 | - | - | 2,535 |
| Components of net loss | - | - | - | - | - | - | (5,823) | (5,823) |
| Employee stock purchase plan | - | - | 14,054 | - | 30 | - | - | 30 |
| Preferred stock conversion | (225) | (56) | 518,055 | 1 | 56 | - | - | 57 |
| Balance at March 31, 2025 | 21,233 | $5,296 | 85,983,677 | $86 | $570,548 | $(206) | $(567,548) | $2,880 |
Three Months Ended March 31, 2026
| Convertible Preferred Stock Series A (Mezzanine) · Common Stock · Additional Paid-In Capital · Treasury Stock · Accumulated Deficit · Total Stockholders’ Equity (Deficit) | ||||||||
|---|---|---|---|---|---|---|---|---|
| (in thousands, except share amounts) | Shares | Amount | Shares | Amount | Amount | Amount | Amount | Amount |
| Balance at December 31, 2025 | 21,008 | 5,240 | 95,339,628 | $95 | $596,960 | $(206) | $(583,368) | $13,481 |
| Stock issued for the exercise of stock options | - | - | 16,036 | - | 24 | - | - | 24 |
| Stock-based compensation | - | - | 115,000 | - | 2,110 | - | - | 2,110 |
| Issuance of common stock through at-the-market offering | - | - | 2,005,308 | 2 | 4,575 | - | - | 4,577 |
| Components of net loss | - | - | - | - | - | - | (5,861) | (5,861) |
| Employee stock purchase plan | - | - | 15,276 | - | 27 | - | - | 27 |
| Balance at March 31, 2026 | 21,008 | $5,240 | 97,491,248 | $97 | $603,696 | $(206) | $(589,229) | $14,358 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.